M
ORTALITY increases notably with advancing age in adult humans. The steep rise of age-specific death rate emerges in most human populations in the fourth decade of life (in the 30s) and progresses throughout most of the remaining years. The elimination of such causes as accidents, homicide, suicide, and infectious and parasitic diseases extrapolates the start of the steep rise to the age of sexual maturity (1) (2) (3) (4) . This age-related increase in mortality is often considered a clear indication of senescent processes that proceed throughout the human life span. The logarithmic mortality curve appears fairly straight throughout most adult ages ( Figure 1) , with a monotonic appearance during most of adult life that could imply a stable and uniform process of progressive senescence. Although the exponential mortality increase tends to slow down at old ages in humans and many other species (5, 6) , usually the deceleration in humans is modest under the age of 100 years (7) , as illustrated in Figure 1 by the slight concavity of mortality curves in the 80s and 90s.
Underlying the progressive mortality increase with age, however, are substantial age-associated changes in the cause of death (COD) structure. As illustrated with the data from France, 1979 France, -1994 Figure 2 , the proportional distribution of deaths by cause changes considerably with advancing age. Mortality due to neoplasms shows this feature strikingly. The proportion increases markedly in the 30s, 40s, and 50s, reaching nearly 45% around age 60. Subsequently, it decreases at older ages to less than 15% from ages 85-89 and further to about 5% among centenarians. However, the proportion of deaths due to cardiovascular diseases continues to rise with age and is more than 40% in the 80s and 90s. Deaths due to respiratory diseases and ''unspecified causes'' become increasingly prevalent at the oldest ages.
Two types of statistical mechanisms could produce these age-associated shifts in COD. First, if death rates from some CODs rise with age faster than others (8) (9) (10) , the proportion of deaths due to those CODs increases with age. This could also occur even if the rate of age-related mortality increase for each COD remains relatively constant over age. (For example, suppose the death rate from a certain disease increases continuously at the constant rate of 15% per year of age. Because this pace is faster than those of most other cause-specific death rates, the proportion of all deaths that are attributed to this disease will continue to rise with age, even though the rate of increase of mortality from the disease remains constant with age.) Second, the COD structure should vary with age if the rate of mortality increase for each COD changes with age, and the direction and extent of the change differ among CODs. It is well established that the rate of mortality rise varies markedly with age for some diseases (8) (9) (10) . Breast cancer is a notable example. This phenomenon seems consistent with observed age variations in rates of some physiological changes (11) (12) (13) (14) (15) .
The age variations in the COD structure suggest that, although the total mortality increases consistently over a wide range of adult age, physiological, pathological, and demographic processes underlying the monotonic appearance may differ considerably among life history stages, such as middle age (later reproductive age) and old age (postreproductive age). According to evolutionary theories of aging, senescence and reproduction are considered to be fundamentally linked to each other because the force of natural selection declines with age (16) (17) (18) (19) (20) . Therefore, the bulk of reproductive effort is accomplished by young adults, with diminishing reproductive contribution at middle ages. At later postreproductive ages, natural selection is predicted to have little effect on the genetic determinants of senescent processes. Thus, the age-related decline in the force of natural selection seems to predict progressive adverse changes in organisms that raise mortality to high levels during the postreproductive phase of life.
If we assume that the mortality increase during the reproductive period and the mortality increase in the postreproductive period are the continuation of the same trend, deaths from chronic diseases in middle age can be considered simply as the results of senescent processes that are prematurely developed or actualized. Because the mortality increase in middle age is gradual and continuous as in old age, chronic processes such as progression of degenerative diseases and increasing vulnerability to infection are likely to be involved. However, chronic processes leading to the early deaths may be initiated or accelerated by factors that are not strongly associated with general senescent processes. They include excessive or unusual exposure to certain environmental risk factors (e.g., cigarette smoking and heavy alcohol consumption); different and more rare genetic risk factors than those that express detrimental effects at postreproductive ages; damages left by certain harmful episodes and conditions (e.g., infections and malnutrition) at young ages and before birth; and noninheritable chance variations during development (39) .
Therefore, the decedents at middle ages may be considered primarily a small and special segment of the Figure 2 . Age pattern of the cause-of-death structure, both sexes, France, 1979-1994 combined. Shaded areas indicate the two age groups, 30-54 years and 65-89 years. Each cause of death (COD) category does not correspond to a curve, but the area between the two adjacent curves. Namely, the proportion of deaths at the given age that are attributable to the COD category is indicated by the vertical distance between two adjoining curves. For example, the proportion of deaths from heart diseases is represented by the distance between the dashed line and dotted line. The dashed line shows the proportion of all deaths at the given age from causes other than infectious and parasitic diseases and neoplasms. At age 60, the dashed line indicates 54%. The dotted line shows the proportion of all deaths from causes other than infectious and parasitic diseases, neoplasms, and heart diseases. At age 60, the dotted line indicates 38%. Thus, the difference (i.e., the vertical distance) between the two curves is the proportion attributable to heart diseases, which is 16% (54%-38%) at age 60. (In this example, age 60 is chosen for simplicity, but actually the proportions are not given for single-year ages but for 5-year age intervals, and points placed at the middle of the intervals are linked by curves.) population with high-risk profiles in terms of these factors. This notion is consistent with the relatively low proportion of all adult deaths that occur at ''middle ages'' in modern human populations. For example, among all decedents aged 15 years or older in France between 1979 and 1994, only 10% was at ages 30-54 years, whereas 67% was at ages 65-89 years.
Thus, we propose the hypothesis that CODs that exhibit a fast mortality increase in middle age and CODs that exhibit a fast mortality increase in old age should be substantially and systematically different, reflecting the differential characteristics of underlying chronic processes. To explore this hypothesis, we compute the rate of agerelated rise in cause-specific mortality for middle age and old age separately, and compare the rate of mortality increase among different CODs and between the two age groups.
METHOD
Two 25-year age groups, 30-54 years and 65-89 years, were selected for ''middle age'' and ''old age,'' respectively. To measure the age-related increase in cause-specific mortality, we fit the Gompertz model to death rates by sex, age, and cause separately for the two age ranges. Because cause-specific mortality data are usually classified by 5-year age intervals, the death rate in the age intervals [x, x þ 5) due to cause i is estimated by
for each sex and for each of the two age ranges. The slope parameter b i is the rate of relative mortality increase with age (RMI).
Variations in RMIs are examined in two different ways: within-age-group comparison and between-age-group comparison. First, CODs that exhibit relatively high RMIs in comparison with other CODs are identified for each of the two age groups. It is expected that the set of CODs that have relatively high RMIs should be substantially and systematically different between middle age and old age. Second, the RMI is compared between middle age and old age for each of the COD categories. The p value for the RMI difference between the two age groups is calculated as a test of significance. It is expected (a) that a number of major CODs have considerably higher RMIs in one of the two age groups than in the other, and (b) that CODs with markedly higher RMIs in middle age than in old age and CODs with markedly higher RMIs in old age than in middle age should be systematically different. Thus, we investigate differential COD profiles of mortality increase in middle age and old age by combining the within-age-group and between-agegroup comparisons.
An alternative to this approach is the life table aging rate analysis, which is useful for examining curvatures of mortality trajectories in detail (6, 10) . The life table aging rate at age x due to cause i is usually calculated bŷ
However, the life For some CODs, it was impossible to calculate RMIs for both of the age ranges using the above-described method. For example, the number of deaths due to ''hyperplasia of prostate'' was zero in some 5-year age intervals between 30 and 54 years, thereby making the left side of Equation 1 to be negative infinity. This COD category, nevertheless, was used as it was without being combined with some other categories, partly because the number of deaths due to this cause in the age group of 65-89 years was sufficiently large enough to produce a reasonably narrow confidence interval for the RMI, and partly because the estimated RMI for 65-89 years was very high and considered noteworthy. Therefore, for some CODs, we show the RMI for one age range only.
The selection of two age groups, 30-54 years and 65-89 years, is based on age patterns of total (all causes combined) mortality in industrialized countries during the latter half of the twentieth century. Although the logarithmic mortality curve appears straight in adult age (Figure 1 ), the life table aging rate analysis, which captures age variations of mortality more sensitively than the semilogarithmic plotting, has revealed that the rate of mortality increase varies systematically with age (6, 23) . Typically, the relative rise remains fairly constant (i.e., Gompertzian) in the 30s and 40s, begins to accelerate further from around age 55 to the late 70s, and decelerate thereafter.
The present analysis does not include the two age groups 55-64 years and 90 years and older, in which deviations from the Gompertz equation are most pronounced because of notable accelerations and decelerations, respectively, of the logarithmic mortality increase. The exclusion of ages 55-64 years, separating 30-54 years and 65-89 years, is also based on the expectation that if middle age and old age are two different mortality regimes, their differences should emerge clearly by excluding the transition phase between the two.
Age patterns of mortality can be investigated crosssectionally (period analysis) or longitudinally (cohort analysis). In this study, period patterns (1979-1994) are analyzed. Period analysis and cohort analysis have relative advantages and disadvantages. Cohort data, which follow the same group of individuals over time, are strongly preferred for investigating effects of individual characteristics on age-related changes in mortality risk.
Cohort data on human mortality, however, have a special limitation. In modern societies, the environment changes considerably during the lifetime of a cohort. Thus, variations of cohort mortality over a long period of time reflect not only age-related changes of the cohort but also substantial changes of the environment (including medical technology and the standard of living). This problem is negligible for cohorts of short-lived animals in well-controlled laboratories, but could produce substantial biases if a human cohort is followed for several decades in a rapidly changing environment. Period data (cross-sectional data on all age groups in a certain period) can help to circumvent a limitation of cohort mortality data.
Furthermore, in most countries, COD data are tabulated by 5-year age intervals but not by year of birth. This makes it difficult to follow cause-specific mortality trajectories of cohorts.
Mortality data from France are used in this analysis. To minimize effects of International Classification of Diseases (ICD) changes, only the data in the ninth revision (ICD9) period, which started in 1979 in France, are analyzed. French data were selected mainly for three reasons. First, reported ages of older persons in some population segments of industrialized countries, including the United States, are not very accurate (24) . Reported ages of older persons in France, however, are considered accurate (25) . Second, a large population size is needed for analyzing causespecific mortality trajectories, because the number of deaths could be very small when deaths are classified by sex, age, and cause. France is the second or third most populous country in Europe (after Germany and just passing the United Kingdom). Thirdly, patterns and historical trends of cause-specific mortality in France have been investigated thoroughly (26, 27) , which helps to interpret results of this study.
We note the caveat that the mortality and morbidity patterns in France may not be typical of other modern populations. As widely known as the ''French paradox,'' mortality and morbidity from ischemic heart diseases in France are low, relative to the levels of saturated fat consumption and serum cholesterol (28, 29) . However, previous demographic studies have shown that age trajectories of adult mortality in France are not particularly unique except for some cohort variations (23, 30) .
The analysis was started with 175 COD categories, and repeated with a gradually decreasing number of COD categories, which was finally reduced to 83 (Table 1) . To obtain statistically reliable results, CODs that had small numbers of deaths and were neighboring within the ICD9 scheme were grouped together. However, caution was exercised to avoid combining CODs that have considerably different RMI values.
CODs are listed in Tables 1-4 in the order of ICD9. Some category names, particularly those including the word ''other,'' differ slightly between Tables 1 and 2 (comprehensive lists) and Tables 3 and 4 (selective lists) because of the different contexts. Data on COD should be used with caution. Because most death certificates are filled out without (or before) autopsy, reported CODs may not be fully accurate. In addition, coding practices may differ among countries and change over time. However, these errors and inconsistencies in the original 4-digit coding are expected to be reduced when those thousands of codes are grouped together (to 83 categories, in this study). Another problem is that a death could occur in the presence of multiple diseases. The physician is supposed to list these diseases and select the one that ''initiated the train of events leading directly to death'' (31) as the underlying cause of death. Interpretation of this definition, however, could be ambiguous in some cases.
Several COD names need additional remarks. The broad category of ''infectious and parasitic diseases'' in ICD includes highly contagious infectious diseases that are relatively prevalent in economically underdeveloped countries (cholera, diphtheria, measles, etc.) but excludes some major infections of heart, lung, kidney, and other organs, which are classified as diseases of the respective physiological systems. For example, viral pneumonia and bacterial pneumonia are not included in ''infectious and parasitic diseases'' but in ''diseases of the respiratory system.'' ICD9 includes Alzheimer's disease (code 331.0) and vascular dementia (as ''arteriosclerotic dementia'' of code 290.4), but their diagnoses in death certificates during the ICD9 period cannot be considered accurate because histopathologic assessment was not generally available. Probably deaths due to Alzheimer's disease or vascular dementia were attributed to a number of different 4-digit ICD codes. In Table  1 , most of those codes are likely to be included in ''other mental disorders,'' ''other diseases of nervous systems and sensory organs,'' ''cerebrovascular disease'' (for some cases of vascular dementia), ''senility without mention of psychosis'' (if dementia is not reported), or ''other ill-defined conditions and symptoms.'' ''Hypertensive disease'' in ICD may be considered a category for residual hypertension-related diseases. It includes hypertensive renal diseases and hypertensive heart failure but excludes some major diseases such as hypertension-related ischemic heart diseases, hypertensive cerebrovascular diseases, and pulmonary hypertension. ''Diseases of arteries, arterioles, and capillaries'' are essentially another category for residuals, excluding major atherosclerotic diseases of the heart, brain, lung, and kidney. Detailed information on exact correspondence between the COD categories used in this study and the 4-digit ICD9 codes can be obtained from the first author (S.H.) upon request. Table 1 shows the proportions of all deaths due to specific causes by sex for age ranges 30-54 years and 65-89 years, thus providing background information on the COD structure of the study population. Table 2 presents numerical results of the data analysis: estimated cause-specific RMIs for each age range, sex, and COD. Important findings in Table 2 are selected and summarized in Tables 3 and 4 .
RESULTS
CODs are listed in those four tables in the order of ICD9 code.
Note that the main focus of this study is on age differentials in cause-specific mortality rises (Tables 2-4) rather than age differentials in prevalence of CODs (Table 1) . For example, the 8th line of the ''neoplasms'' section of Table 2 shows that the death rate due to malignant neoplasm of the larynx is estimated to rise with age in males aged 30-54 years at the exponential rate of 0.1806 (corresponding to the geometric rate of 19.79%) per year of age. The rate is 0.0058 in ages 65-89 years, thus the difference between the two age groups is ÿ0.1749. The difference is statistically significant and large enough to include malignant neoplasm of the larynx in Table 3 , which lists CODs that exhibit fast mortality increase in middle age.
For some CODs, Tables 1 and 2 may appear inconsistent. Even though their RMIs in Table 2 decline from middle to old age, Table 1 shows that their proportions increase from middle to old age. For example, the RMI for ''chronic bronchitis and emphysema'' in males decreases from 0.1635 for ages 30-54 years to 0.1374 for ages 65-89 years, but its proportion of all-male deaths increases from 0.28% for ages 30-54 years to 1.75% for ages 65-89 years. This is possible because, if the RMI for a COD remains consistently higher than the RMI for total mortality throughout a certain age range, the proportion of deaths due to the COD keeps increasing in the age range, whether the RMI rises or declines. Tables 3 and 4 show selected CODs that have particularly high RMIs at middle ages and old ages, respectively. As described earlier, RMIs can be compared among different CODs within the same age group, and for the same COD between the two age groups. These two different modes of comparison correspond, respectively, to the columns labeled WAG (within-age-group comparison) and BAG (betweenage-group comparison) in Tables 3 and 4 . Thus, for each of the 4 sex-age categories (2 sexes 3 2 age groups), CODs that meet either one of the following two conditions are selected: (a) the RMI for the COD is higher than the RMI for all causes in the same age group by 0.03 or more; (b) the RMI for the COD in the age group is higher than the RMI for the same COD in the other age group by 0.05 or more. A difference of 0.03 in the RMI is substantial in that the ratio of two cause-specific death rates would double in 23 years (of age) if the difference continues.
These two arbitrary criteria are used because, in this study, the conventional tests of statistical significance are not very useful for identifying important CODs. For example, Table 2 shows 154 RMI differences between middle age and old age males and females, and 83% of the differences are statistically significant ( p , .01). Because of the large number of deaths, which were recorded in the entirety of France during the 16-year period, a small observed difference that is usually considered insignificant from a substantive viewpoint could pass the conventional test of statistical significance. Recall that the statistical significance indicates that the difference in the population is unlikely to be exactly zero, but the difference may still be close to zero if the sample size is large. Tables 3 and 4 reveal that the COD profile of mortality increase is strikingly different between middle age and old age. Out of 83 CODs in Table 2, 35 CODs and 32 CODs  were selected for Tables 3 and 4 , respectively, with only 6 overlapping CODs. Thus, according to the two criteria for mortality increase, the majority (70%) of CODs can be unambiguously split into the middle-age type and old-age type, roughly 50-50.
CODs that have high RMIs at middle ages (Table 3 ) include malignant neoplasms at various sites, acute myocardial infarction, ischemic heart diseases other than acute myocardial infarction, chronic rheumatic heart disease, hypertensive disease, chronic liver disease (both alcoholic and nonalcoholic), alcohol-related mental disorder, and multiple sclerosis. It should be noted that two major disease groups, malignant neoplasms and ischemic heart diseases, exhibit markedly rapid mortality increase in middle age.
It also seems important to notice that the list suggests strong involvement of some risk factors such as heavy drinking (alcoholic psychosis, alcohol dependence syndrome, and chronic alcoholic liver disease), disease history (acute rheumatic fever for chronic rheumatic heart disease and hepatitis B and C for nonalcoholic liver cirrhosis), and genetic factors (multiple sclerosis and subtypes of some malignant neoplasms). In addition, Table 2 shows that RMI differences between middle ages and old ages are generally greater for malignant neoplasms of respiratory organs than for most other malignant neoplasms, particularly among males, which may suggest stronger effects of smoking or environmental aerosols on the RMI in middle age than in old age.
The COD profile of mortality increase changes notably from middle age to old age. The increase of mortality from malignant neoplasms slows down considerably. As for cardiovascular diseases, the rise of mortality from ischemic heart diseases decelerates, but that from ''other heart diseases'' (mainly heart failure) and cerebrovascular disease accelerates.
In the list of CODs with high RMIs at old ages (Table 4 ), the following 6 points seem noteworthy.
1. The list includes several diseases that are always or usually caused by infection: acute respiratory infections, influenza, pneumonia, ''osteomyelitis, periostitis, and other infections involving bone,'' intestinal infectious diseases, and viral diseases (ICD9 codes 045-079). 2. The list also includes CODs that are related to a frail musculoskeletal system (including muscles of internal organs) and/or inappropriate neural control, such as accidental falls, accidental inhalation/ingestion of foreign bodies, accidents caused by fire and flames, and intestinal obstruction (without mention of hernia). 3. Rapidly becoming prevalent are two ''vague'' COD categories, ''senility without mention of psychosis'' and ''other ill-defined conditions and symptoms.'' 4. The COD list for old age (Table 4 ) appears pathologically more diverse than that for middle age (Table 3) , including diseases of the genitourinary, integumentary, and musculoskeletal systems. Although Table 4 has slightly fewer COD categories than Table 3 , about one half of the CODs in Table 3 are malignant neoplasms. 5 . Some relatively common diseases and injuries that seldom cause deaths at younger adult ages emerge as serious threats at older ages. They include anemia, influenza, skin diseases, and accidental inhalation/ ingestion. 6. Table 4 includes nonalcoholic mental disorders, into which many deaths with vascular dementia or Alzheimer disease might have been classified. Tables 3 and 4 , for two different reasons. First, 4 CODs have opposite age patterns of RMIs for males and females, and were selected for males in Table  3 and for females in Table 4 . These CODs are ''diseases of arteries, arterioles, and capillaries,'' ''chronic bronchitis and emphysema,'' ''pneumoconiosis and other lung disease due to external agents,'' and ''noninfective enteritis and colitis.'' The sex differences may be partly due to higher exposure of middle-age males to some environmental risk factors such as smoking (for chronic bronchitis and emphysema) and occupational hazards (for pneumoconiosis and other lung disease due to external agents).
Six CODs appear in both
Second, some CODs have fast age-related increases of mortality in both middle and old age. RMIs for ''chronic bronchitis and emphysema,'' ''hernia of abdominal cavity,'' and ''other diseases of genital organs'' were higher than the RMI for all causes by .03 or more at both middle ages and old ages, for both males or females. In addition, a number of CODs have consistently high rates of age-related mortality increase in both middle and old ages, even though their rates of increase do not remain constant over age. In general, rates of increase in mortality from renal-cardiovascular disease categories tend to be high throughout adult ages. This suggests that caution should be exercised not to overemphasize the differences between middle age and old age and overlook their commonalities. Figure 3 displays some typical age trajectories of mortality for selected CODs that have higher RMIs at middle ages than old ages (3A) and CODs that have the opposite patterns (3B). The mortality curves tend to be concave in (A) and convex in (B), particularly around age 60.
DISCUSSION
This analysis shows striking differences in the rates of changes for particular causes of death during middle age and old age. These two broad age groups are characterized by different profiles of mortality increase with advancing age.
The mortality rise in middle age (30-54 years) is dominated by major degenerative diseases such as malignant neoplasms, atherosclerosis, hypertension, cirrhosis, ulcer, and diabetes. These diseases tend to progress over several decades, with mortality risks that affect a subgroup of middle-aged individuals. In some cases, familial trends are associated with common genetic risk factors, such as apoE4 (apolipoprotein E4), a common allele that has a significant but modest association with increased cholesterol and with the risk of cardiovascular disease, particularly in middle age (32, 33) . Overall, the incidence of dominant genes for specific causes of mortality at middle ages and later is emerging as less common, whereas environmental factors are increasingly recognized (34) . These perspectives do not rule out rare genes that promote longevity in diverse environments, such as may be found in some families (35, 36) . Other individuals may be at high risk from environmental exposure such as cigarette smoking, heavy alcohol consumption, high-fat and high-calorie diet, and occupational hazard. Another set of risk factors arises from low birth weight syndromes, which increase the risk of adult onset diabetes (type II), heart disease, and hypertension. Low birth weight with accelerated childhood growth, which occurs in many populations even in the absence of clinically defined maternal malnutrition, has not been associated with common genetic risk factors (37, 38) . Childhood infections can also cause adult mortality before old age, e.g., streptococcus infections are associated with a high incidence of focal myocardial damage (Ref. 19: pp. 492-493) .
Another category of high risk may be acquired through random cellular events during development, e.g., events that lead to variations in vascular branching patterns, so that occlusions or aneurysms can have very different effects Endocrine, nutritional, and metabolic diseases, and immunity disorders
Diabetes mellitus þ
Mental disorders, and diseases of the nervous system and sense organs
Diseases of the circulatory system Notes: A plus sign for WAG indicates a notably faster mortality increase by within-age-group (WAG) comparison, i.e., RMI (relative mortality increase) for the cause in middle age is greater than RMI for all causes in middle age by 0.03 or more. A plus sign for BAG indicates a notably faster mortality increase by between-age-group (BAG) comparison, i.e., RMI for the cause in middle age is greater than RMI for the same cause in old age by 0.05 or more.
a Excluding all of the 19 specific sites of malignant neoplasm in Table 1 . Excluding hypertension-related ischemic heart disease and cerebrovascular disease, and pulmonary hypertension. 
Diseases of the blood and blood-forming organs
Mental disorders (excluding alcoholic psychoses and alcohol dependence syndrome)
Diseases of the circulatory system
Other heart diseases Notes: A plus sign for WAG indicates a notably faster mortality increase by within-age-group (WAG) comparison, i.e., RMI (relative mortality increase) for the cause in old age is greater than RMI for all causes in old age by 0.03 or more. A plus sign for BAG indicates a notably faster mortality increase by betweenage-group (BAG) comparison, i.e., RMI for the cause in old age is greater than RMI for the same cause in middle age by 0.05 or more. a Excluding chronic rheumatic heart disease, hypertensive heart disease, and ischemic heart disease. Tables 3 and 4. c Excluding heart disease, hypertensive disease, cerebrovascular disease, diseases of arteries, arterioles, and capillaries, phlebitis, thrombophlebitis, and venous embolism and thrombosis. Excluding acute respiratory infections, influenza, pneumonia, chronic bronchitis, emphysema, asthma, bronchiectasis, and other chronic obstructive pulmonary disease, pneumoconiosis, and other lung disease due to external agents. The age-related rise in total mortality at old ages appears strongly associated with the gradual and progressive declines of various physiological functions. The deterioration may be attributable to long-term accumulation of small damages and/or debilitation by previous diseases. The aging immune and pulmonary systems increase the vulnerability to certain other infectious diseases. The frail musculoskeletal system and declining functions of neural control mechanisms and sensory organs raise the risk of certain types of accidents. Chronic cardiovascular diseases such as atherosclerosis and hypertension debilitate the heart, eventually leading to death from heart failure. Due to the declining ability to maintain homeostasis, physiological stresses that were not serious at younger ages become life threatening at old ages. Because of the simultaneous deterioration of multiple physiological systems, an increasing number of deaths occur in the presence of multiple diseases or without explicit manifestation of any specific diseases, making it more likely for physicians to use vague categories in the death certificates. The vulnerability to multiple pathologies is also reflected in the diversity of CODs at old ages. These physiological declines probably occur in most (if not all) individuals, though there may be substantial individual differences in the pace of decline. As discussed above, individual risk profiles may be subject to different types of random experiences during development, which cause minor deficits early in life to which are added random further insults, e.g., turbulent flow favors atherogenesis (42, 43) .
In summary, the mortality rise in middle age seems primarily attributable to specific chronic diseases that develop prematurely in high-risk individuals, whereas the mortality increase in old age seems dominated by senescent processes that eventually raise the general vulnerability of almost all individuals to multiple pathologies. The high-risk individuals at middle ages may have experienced unusually high exposure to some environmental hazards, have relatively uncommon genes that express adverse effects, or have specific disease histories or congenital defects. The difference can be considered to correspond, to some extent, to the conventional division of ''disease versus normal aging'' (44) .
The idea that a few fundamentally different types of mortality force underlie observed variations of death rates is not new and has a long history (1) . There are a number of versions of mortality partition, but they generally distinguish extrinsic mortality, which is either caused or initiated by something that originates outside the body, and intrinsic mortality, which is either caused or initiated by processes that originate within the body (1) . This distinction between extrinsic and intrinsic mortality may not appear to be closely related to the differences in the COD profile of mortality rise between middle age and old age. Most CODs listed in Tables 3 and 4 are usually considered intrinsic (45), which is not surprising because gradual increases of cause-specific mortality in adult age are likely associated with chronic processes.
However, extrinsic and intrinsic factors may interact in causing a death, and extrinsic factors seem more strongly involved in chronic diseases that exhibit fast mortality increase in middle age than those in old age, even though the chronic diseases may be considered primarily intrinsic. Death rates from various malignant neoplasms, alcoholrelated mental disorders, acute myocardial infarction, and chronic liver diseases rise faster in middle age than in old age. These diseases are generally considered relatively strongly associated with behavioral factors (e.g., smoking, alcohol consumption, diet, and exercise) and occupational hazards.
The relationships between the extrinsic-versus-intrinsic dichotomy and the RMI differences between middle age and old age, however, do not seem very simple. Relatively uncommon genetic risk factors, which are intrinsic, may be involved in some of the deaths from certain CODs that exhibit faster mortality increase in middle age than in old age. They include multiple sclerosis, diabetes mellitus, and several types of malignant neoplasms. Death rates for some types of accidents and infectious diseases rise more steeply in old age than in middle age, suggesting that the vulnerability to those extrinsic risks is greatly raised by intrinsic chronic processes. 
Conclusion
This exploratory study indicates that relationships between senescent processes and the age-associated mortality increase are not so simple and straightforward as previously thought. The straight appearance of logarithmic mortality curves is widely considered as an indication of senescent processes that continue throughout most adult ages. However, our analysis of COD patterns suggest that physiological, pathological, and demographic processes underlying the consistent rise in total mortality may be substantially different between middle age and old age.
